FDAnews Drug Daily Bulletin

Boehringer Ingelheim, the ETH Zurich Announce Diabetes and Obesity Research Collaboration

Sept. 10, 2012
Boehringer Ingelheim, the Institute of Molecular Health Science and the Institute of Food, Nutrition and Health of the ETH Zurich will collaborate to achieve new insights into the development of diabetes and obesity. The joint effort will focus on investigating three cell types that may contribute to the onset of diseases such as obesity and diabetes because of their dominant role in metabolic homoeostasis.
Pipeline Review